Aus firm develop hair test from breast cancer
This article was originally published in Clinica
An Australian firm is developing a test that can detect breast cancer from hair samples. Sydney-based Fermiscan told Clinica that the test could become available in Australia as early as this year, and will be marketed in other countries once the firm has regulatory approval and licensing agreements in place.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.